Mostrar el registro sencillo del ítem
The short-term cost-effectiveness of once-weekly semaglutide versus once-weekly dulaglutide for the treatment of type 2 diabetes mellitus in Colombian adults
dc.contributor.author | Liebisch-Rey H. | |
dc.contributor.author | Suarez-Chacon AM. | |
dc.contributor.author | Fuentes YV. | |
dc.date.accessioned | 2025-04-02T18:02:49Z | |
dc.date.available | 2025-04-02T18:02:49Z | |
dc.date.issued | 2023 | |
dc.identifier.citation | Liebisch-Rey H, Suarez-Chacon AM, Fuentes YV et al. The short-term cost-effectiveness of once-weekly semaglutide versus once-weekly dulaglutide for the treatment of type 2 diabetes mellitus in Colombian adults [version 2; peer review: 2 approved]. F1000Research 2023, 12:914 (https://doi.org/10.12688/f1000research.128441.2) | es_CO |
dc.identifier.other | https://f1000research.com/articles/12-914 | |
dc.identifier.uri | http://hdl.handle.net/10818/64124 | |
dc.description.abstract | Type 2 Diabetes Mellitus (T2DM) is a highly prevalent disease worldwide and in Colombia, representing one of the main causes of death and placing a considerable burden on healthcare systems. 13 classes of drugs are approved for the treatment of T2DM, with Glucagon-like Peptide-1 (GLP-1) receptor agonists being a first-line treatment option for patients with or at high risk of certain cardiovascular diseases and chronic kidney disease. The objective of this study is to conduct a short-term cost-effectiveness analysis of once-weekly semaglutide versus once-weekly dulaglutide in Colombian adults with T2DM, from a third-party payer perspective. | en |
dc.format | application/pdf | es_CO |
dc.language.iso | eng | es_CO |
dc.publisher | F1000Research | es_CO |
dc.relation.ispartofseries | F1000Research 2023 | |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject.other | Semaglutida | |
dc.subject.other | Dulaglutida | |
dc.subject.other | Farmacoeconómica | |
dc.subject.other | Costo-efectividad | |
dc.title | The short-term cost-effectiveness of once-weekly semaglutide versus once-weekly dulaglutide for the treatment of type 2 diabetes mellitus in Colombian adults | en |
dc.type | journal article | es_CO |
dc.type.hasVersion | publishedVersion | es_CO |
dc.rights.accessRights | openAccess | es_CO |
dc.identifier.doi | 10.12688/f1000research.128441.2 |
Ficheros en el ítem
Ficheros | Tamaño | Formato | Ver |
---|---|---|---|
No hay ficheros asociados a este ítem. |
Este ítem aparece en la(s) siguiente(s) colección(ones)
-
Facultad de Medicina [1517]